Ind-Swift Ltd.
Snapshot View

9.55 -0.28 ▼-2.9%

03 February 2023, 04:01:00 PM
Volume: 2,393

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indswift.com
Market Cap 50.86 Cr.
Enterprise Value(EV) 1,081.26 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -6.93 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.22 Trailing Twelve Months Ending 2022-09
Book Value / Share -137.79 Trailing Twelve Months Ending 2022-09
Price to Book Value -0.07 Calculated using Price: 9.39
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 5.42 Cr. 54,164,653 Shares
FaceValue 2
Company Profile
Ind-Swift Limited was incorporated as a public limited company on June 6, 1986 under the Companies Act 1956.It is the flagship company of India based Ind Swift Group. Ind-Swift Limited is a north India based pharmaceutical company.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.85%
1 Week
-8.96%
1 Month
-20.48%
3 Month
+4.14%
6 Month
-9.65%
1 Year
-32.13%
2 Year
+114.61%
5 Year
+12.88%
10 Year
-26.71%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -112.51
Return on Capital Employed (%) -4.27 -10.41 -20.35 -56.22 -10.31 3.37 5.82 7.19 11.69
Return on Assets (%) -8.26 -11.09 -17.47 -42.12 -8.45 1.35 -3.19 -4.68 -3.07

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 108 -40 -239 -611 -679 -677 -713 -695 -720 -746
Non Curr. Liab. 596 549 679 672 694 659 661 661 634 638
Curr. Liab. 686 718 621 608 598 616 654 706 718 732
Minority Int.
Equity & Liab. 1,390 1,228 1,061 669 613 598 602 672 632 623
Non Curr. Assets 506 469 439 463 427 405 373 406 389 391
Curr. Assets 851 738 612 206 186 194 229 265 242 232
Misc. Exp. not W/O 33 21 10
Total Assets 1,390 1,228 1,061 669 613 598 602 672 632 623

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 570 417 304 263 270 289 330 356 398 408
Other Income 13 2 13 14 15 8 22 15 24 12
Total Income 583 419 317 277 284 297 352 371 421 421
Total Expenditure -604 -487 -461 -328 -264 -278 -306 -315 -352 -370
PBIDT -21 -68 -144 -52 21 19 46 57 69 50
Interest -77 -40 -19 -16 -11 -4 -35 -52 -57 -58
Depreciation -26 -39 -36 -36 -35 -34 -34 -33 -32 -30
Taxation 9 2 0 -1 -1 -2 0 0
Exceptional Items -260 -28 27 6 -1 1 1
PAT -116 -145 -200 -364 -54 8 -19 -30 -20 -38
Adjusted EPS -23 -29 -40 -67 -10 2 -4 -6 -4 -7

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -146 103 86 -106 7 1 43 35 83 90
Cash Fr. Inv. -28 -14 -6 -4 -4 -3 -14 -11 -17 -18
Cash Fr. Finan. 146 -89 -81 110 -11 -4 -13 -26 -54 -84
Net Change -28 0 -1 0 -8 -5 16 -3 12 -13
Cash & Cash Eqvt 18 18 17 17 9 4 20 17 29 16

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 55.55 55.55 55.55 55.55 55.55 55.58 55.58 55.58 55.58
Public 44.45 44.45 44.45 44.45 44.45 44.42 44.42 44.42 44.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 73.46 73.46 73.46 73.46 73.46 73.43 42.81 42.81 42.81

Announcements View Details >>

Sat, 28 Jan 2023
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results For Quarter And Nine Months Ended 31St December 2022.
IND-SWIFT LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1)(a) of the Securities & Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations 2015 notice is hereby given that the meeting of Board of Directors of the Company is scheduled to be held on Monday 13th February 2023 inter-alia to consider approve and take on record the Un-audited Financial Results of the Company for the Quarter and nine months ended December 31 2022.
Tue, 10 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
In compliance with regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 please find enclosed a copy of the certificate dated 7th January 2023 received from Alankit Assignments Limited Registrar and Transfer Agent of the Company for the quarter ended 31st December 2022. You are requested to take the above information in your record.
Fri, 30 Dec 2022
Closure of Trading Window
This is to inform the Exchange that as per the Companys Code of Conduct for prevention of Insider Trading read with Regulation 4 of the Schedule B of SEBI (Prohibition of Insider Trading) Regulations 2015 and notification no. NSE/CML/2019/11 and LIST/COMP/01/2019-20 issued respectively by NSE and BSE on 2nd April 2019 the Trading Window for dealing in Equity Shares of the Company shall remain closed for all Promoters members of the Promoter Group Directors/Officers/Designated Employees covered under the said code from the start of business hours at 9:00 A.M. on 1st January 2023 till 48 hours from the conclusion of the Board Meeting to be held for the purpose of consideration of Un-Audited Financial Results for the quarter ended 31st December 2022.

Technical Scans View Details >>

Fri, 03 Feb 2023
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Entering 52 Week Low Zone Close Entering 52 Week Low Zone
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On Ind-Swift Ltd.

What is Ind-Swift share price?

Can I buy Ind-Swift shares now?

What is the Market Cap of Ind-Swift?

What is the 52 Week High and Low of Ind-Swift?

What is the trend of Ind-Swift share price?